文献速递前列腺增生与排尿功能障碍男科与性医学

机器人辅助前列腺周围人工尿道括约肌植入术治疗男性神经源性压力性尿失禁:手术技术描述及与开放入路长期功能结果的比较

Robot-assisted Periprostatic Artificial Urinary Sphincter Implantation in Men with Neurogenic Stress Urinary Incontinence: Description of the Surgical Technique and Comparison of Long-term Functional Outcomes with the Open Approach.
PubMed 文献 · Eur Urol · 2023-10-30

回顾性分析2000至2022年单中心65例神经源性压力性尿失禁男性,33例行开放pAUSi、32例行机器人辅助pAUSi。机器人组手术时间、出血量、住院时间更优,Clavien-Dindo≥3a并发症更少,完全控尿率与开放组相当,无修复生存期有延长趋势但未达统计学显著。

要点

  • 机器人辅助pAUSi较开放pAUSi手术时间更短、出血更少、住院时间更短。
  • 机器人组Clavien-Dindo≥3a并发症1/32(3%)低于开放组10/33(30%)。
  • 两组完全控尿率(零尿垫)相当:机器人组24/32(75%) vs 开放组24/33(73%)。

核心结论

  • 机器人辅助pAUSi是开放pAUSi的有效替代方案,手术时间更短、出血更少、严重并发症更少、住院时间更短,功能结果与修复手术需求相似。

研究设计与样本

  • 回顾性收集2000至2022年一家三级中心连续65例神经源性压力性尿失禁男性的数据,33例行开放pAUSi、32例行机器人辅助pAUSi。
  • 开放pAUSi由一位擅长功能性泌尿外科与假体手术的术者完成,机器人辅助pAUSi由同一术者与另一位擅长机器人手术的术者共同完成。

主要发现

  • 中位(四分位距)手术时间:机器人辅助pAUSi 170(150-210)分钟 vs 开放pAUSi 245(228-300)分钟,p<0.001。
  • 中位(四分位距)估计出血量:机器人辅助pAUSi 20(0-50)ml vs 开放pAUSi 500(350-700)ml,p<0.001。
  • 中位(四分位距)住院时间:机器人辅助pAUSi 5(4-6)天 vs 开放pAUSi 11(10-14)天,p<0.001。
  • Clavien-Dindo≥3a并发症:机器人辅助pAUSi 1/32(3%) vs 开放pAUSi 10/33(30%),p=0.014。
  • 完全控尿(零尿垫):机器人辅助pAUSi 24/32(75%) vs 开放pAUSi 24/33(73%),p=0.500;中位随访时间分别为开放pAUSi 118(50-183)个月与机器人辅助pAUSi 56(25-84)个月,p<0.001;机器人辅助pAUSi组无修复生存期有延长趋势(p=0.076)。

临床怎么用

  • 原文结论认为机器人辅助pAUSi是开放pAUSi的有效替代方案,可缩短手术时间、减少出血、减少严重并发症并缩短住院时间,功能结果与修复手术需求相似。

局限性

  • 主要研究局限性为回顾性性质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprostatic artificial urinary sphincter implantation (pAUSi) is a rare yet relevant indication for male neurogenic stress urinary incontinence (SUI). OBJECTIVE: To describe the surgical technique of robot-assisted pAUSi (RApAUSi) and compare the long-term functional results with the open pAUSi (OpAUSi). DESIGN, SETTING, AND PARTICIPANTS: Data of 65 consecutive men with neurogenic SUI undergoing pAUSi between 2000 and 2022 in a tertiary centre were collected retrospectively. SURGICAL PROCEDURE: Thirty-three patients underwent OpAUSi and 32 underwent RApAUSi. OpAUSi cases were performed by a single surgeon, experienced in functional urology and prosthetic surgery. RApAUSi cases were performed by the same surgeon together with a second surgeon, experienced in robotic surgery. MEASUREMENTS: Outcome measures were achievement of complete urinary continence, intra- and postoperative complications, and surgical revision-free survival (SRFS). RESULTS AND LIMITATIONS: RApAUSi showed superior results to OpAUSi in terms of median (interquartile range) operative time (RApAUSi: 170 [150-210] min vs OpAUSi: 245 [228-300] min; p < 0.001), estimated blood loss (RApAUSi: 20 [0-50] ml vs OpAUSi: 500 [350-700] ml; p < 0.001), and median length of hospital stay (LOS; RApAUSi: 5 [4-6] d vs OpAUSi: 11 [10-14] d; p < 0.001). Clavien-Dindo grade ≥3a complications occurred more frequently after OpAUSi (RApAUSi: 1/32 [3%] vs OpAUSi: 10/33 [30%]; p = 0.014). Achievement of complete urinary continence (zero pads) was comparable between the groups (RApAUSi: 24/32 [75%] vs OpAUSi: 24/33 [73%]; p = 0.500). The median follow-up periods were 118 (50-183) and 56 (25-84) mo for OpAUSi and RApAUSi, respectively (p < 0.001). A tendency towards longer SRFS was observed in the RApAUSi group (p = 0.076). The main study limitation was its retrospective nature. CONCLUSIONS: RApAUSi is an efficient alternative to OpAUSi, resulting in shorter operative times, less blood loss, fewer severe complications, and a shorter LOS with similar functional results and need for revision surgery. PATIENT SUMMARY: Compared with open periprostatic artificial urinary sphincter implantation (pAUSi), robot-assisted pAUSi leads to faster recovery and similar functional results, with fewer postoperative complications.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Lambert E, Chartier-Kastler E, Vaessen C, et al. Robot-assisted Periprostatic Artificial Urinary Sphincter Implantation in Men with Neurogenic Stress Urinary Incontinence: Description of the Surgical Technique and Comparison of Long-term Functional Outcomes with the Open Approach. Eur Urol. 2023. PMID: 37914580. doi:10.1016/j.eururo.2023.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。